Lyophilized pegaspargase (S95014)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lyophilized pegaspargase (S95014), covering 2023-12-29 to 2023-12-29. Get the full timeline:
Most recent: Clinical Trial Update: A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL) [Phase 2]